In last trading session, Opus Genetics Inc (NASDAQ:IRD) saw 0.4 million shares changing hands with its beta currently measuring 0.20. Company’s recent per share price level of $0.98 trading at -$0.01 or -0.87% at ring of the bell on the day assigns it a market valuation of $30.89M. That closing price of IRD’s stock is at a discount of -246.94% from its 52-week high price of $3.40 and is indicating a premium of 17.35% from its 52-week low price of $0.81. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.31 million shares which gives us an average trading volume of 183.62K if we extend that period to 3-months.
Opus Genetics Inc (NASDAQ:IRD) trade information
Upright in the red during last session for losing -0.87%, in the last five days IRD remained trading in the red while hitting it’s week-highest on Friday, 12/20/24 when the stock touched $0.98 price level, adding 10.91% to its value on the day. Opus Genetics Inc’s shares saw a change of -67.49% in year-to-date performance and have moved -4.07% in past 5-day. Opus Genetics Inc (NASDAQ:IRD) showed a performance of -0.15% in past 30-days. Number of shares sold short was 0.88 million shares which calculate 4.69 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Opus Genetics Inc (IRD) estimates and forecasts
Statistics highlight that Opus Genetics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -38.84% of value to its shares in past 6 months, showing an annual growth rate of -165.22% while that of industry is 17.40. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -6.57% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 11.1M for the same. And 1 analysts are in estimates of company making revenue of 2M in the next quarter. Company posted 1.69M and 1.71M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 53.36% during past 5 years.
